Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-25 @ 12:43 AM
NCT ID:
NCT04531267
Eligibility Criteria:
Inclusion Criteria:
* Hypertensive patients that received only one type of medication.
* Uncontrolled blood pressure: 140mmHg≤SBP≤149mmHg, 90mmHg≤DBP≤99mmHg.
* Able to sign informed consent and come to follow-up session by themselves.
Exclusion Criteria:
* Type 1 or 2 diabetic patients, or taking anti-diabetic drugs.
* Taking two types or above anti-hypertensive drugs
* Alanine transaminase or Aspartate Transaminase exceeding normal limits for 2 times or above.
* Acute myocardial infarction, heart failure or stroke in the last 6 months.
* Suffering from chronic gastrointestinal diseases
* Taking calcium or magnesium supplements in a regular basis (at least once per week) in the previous year
* In pregnancy or breastfeeding period, or planning to be pregnant
* Other serious diseases (e.g. cancer) that are not eligible for participation
* Participating in other studies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
79 Years
Study:
NCT04531267
Study Brief:
Protocol Section:
NCT04531267